| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9b3517ffc27473f4d053401316159e39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_622ccfa0812223f77f7b9badeccb5d19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_963afa89016d1fe68fe0b1e37184eea8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_49c96e6f65e6b529165bb21186a0f527
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_96eddd31165955882708d73c89118259 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-353
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-353
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 |
| filingDate |
2010-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb9394cb16b1081f8e443346e6c286b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_853450492395228ee6d9315fc4125c29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a7ad0db9780779a8f81b941bad3b3eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f2b2f198a7bb51e2f44c34a67e3a65a |
| publicationDate |
2012-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8198249-B2 |
| titleOfInvention |
Methods and compositions for the treatment of obesity, insulin related diseases and hypercholesterolemia |
| abstract |
A process of enhancing insulin excretion in a subject includes administering to the subject a polyphenol active ingredient. The polyphenol active ingredient is a purified cyanidin-3-glycoside alone or purified cyanidin alone. The pharmaceutically acceptable carrier is administered with the polyphenol active ingredient. |
| priorityDate |
2004-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |